John G. Cox's most recent trade in Dyne Therapeutics Inc was a trade of 100,000 Common Stock done at an average price of $9.1 . Disclosure was reported to the exchange on July 14, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dyne Therapeutics Inc | John G. Cox | Director, CEO & President | Purchase of securities on an exchange or from another person at price $ 9.11 per share. | 14 Jul 2025 | 100,000 | 242,179 | - | 9.1 | 911,000 | Common Stock |
| Dyne Therapeutics Inc | John G. Cox | Director, CEO & President | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Jul 2025 | 10,000 | 202,179 | - | 0 | Common Stock | |
| Dyne Therapeutics Inc | John G. Cox | Director, CEO & President | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Jul 2025 | 10,000 | 212,179 | - | 0 | Common Stock | |
| Dyne Therapeutics Inc | John G. Cox | Director, CEO & President | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Jul 2025 | 10,000 | 222,179 | - | 0 | Common Stock | |
| Dyne Therapeutics Inc | John G. Cox | Director, CEO & President | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Jul 2025 | 10,000 | 232,179 | - | 0 | Common Stock | |
| Dyne Therapeutics Inc | John G. Cox | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 13.35 per share. | 05 Jun 2025 | 4,060 | 142,179 | - | 13.4 | 54,201 | Common Stock |
| Dyne Therapeutics Inc | John G. Cox | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 11.83 per share. | 05 Mar 2025 | 4,061 | 146,239 | - | 11.8 | 48,042 | Common Stock |
| Dyne Therapeutics Inc | John G. Cox | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2024 | 232,100 | 232,100 | - | - | Stock option (right to buy) | |
| Dyne Therapeutics Inc | John G. Cox | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2024 | 145,300 | 150,300 | - | 0 | Common Stock | |
| Dyne Therapeutics Inc | John G. Cox | Director, CEO & President | Purchase of securities on an exchange or from another person at price $ 33.09 per share. | 04 Sep 2024 | 7,200 | 8,000 | - | 33.1 | 238,248 | Common Stock |
| Dyne Therapeutics Inc | John G. Cox | Director, CEO & President | Purchase of securities on an exchange or from another person at price $ 33.09 per share. | 04 Sep 2024 | 7,200 | 8,000 | - | 33.1 | 238,248 | Common Stock |
| Dyne Therapeutics Inc | John G. Cox | Director, CEO & President | Purchase of securities on an exchange or from another person at price $ 33.09 per share. | 04 Sep 2024 | 7,200 | 8,000 | - | 33.1 | 238,248 | Common Stock |
| Dyne Therapeutics Inc | John G. Cox | Director, CEO & President | Purchase of securities on an exchange or from another person at price $ 33.09 per share. | 04 Sep 2024 | 7,200 | 8,000 | - | 33.1 | 238,248 | Common Stock |
| Dyne Therapeutics Inc | John G. Cox | Director, CEO & President | Purchase of securities on an exchange or from another person at price $ 32.57 per share. | 04 Sep 2024 | 800 | 800 | - | 32.6 | 26,056 | Common Stock |
| Dyne Therapeutics Inc | John G. Cox | Director, CEO & President | Purchase of securities on an exchange or from another person at price $ 32.57 per share. | 04 Sep 2024 | 800 | 800 | - | 32.6 | 26,056 | Common Stock |
| Dyne Therapeutics Inc | John G. Cox | Director, CEO & President | Purchase of securities on an exchange or from another person at price $ 32.57 per share. | 04 Sep 2024 | 800 | 800 | - | 32.6 | 26,056 | Common Stock |
| Dyne Therapeutics Inc | John G. Cox | Director, CEO & President | Purchase of securities on an exchange or from another person at price $ 32.57 per share. | 04 Sep 2024 | 800 | 800 | - | 32.6 | 26,056 | Common Stock |
| Dyne Therapeutics Inc | John G. Cox | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2024 | 679,853 | 679,853 | - | - | Stock Option (Right to Buy) |